Healing the Heart: Third Annual Cardiology Symposium of the Central Coast

Other

633 E. Cabrillo Blvd.,Santa Barbara CA 93103

24 February, 2023

Description

Healing the Heart 2023Third Annual Cardiology Symposium by Cottage Health, Friday, February 24, 2023 Hilton Santa Barbara Beachfront Resort Featuring nationally recognized guest speakers including local experts from the Heart & Vascular Center at Cottage Health. If you would like to book a hotel room at the Hilton with a reduced rate, please click here. Limited availability, reservations are on a first-come first-served basis. To register virtually click here. Audience This symposium is designed for cardiologists, cardiac surgeons, physicians in training, registered nurses, nurse practitioners, family practice/internal medicine physicians, hospitalists, physician assistants, cardiology technologists, and other healthcare practitioners involved in the care planning of patients with cardiovascular disease. Course Objectives Summarize the diagnostic features and management of spontaneous coronary artery dissection (SCAD).Review the clinical evidence supporting vein of Marshall ethanol and its emerging roles in ventricular tachycardias. Examine the pathophysiologic basis of guideline-directed medical therapy in heart failure with reduced ejection fraction (HFrEF), as well as treatment strategies.Discuss risk stratification, new treatments, and the role of advance imaging in hypertrophic cardiomyopathy (HCM). Summarize the direct and indirect effects of COVID-19 on cardiovascular disease and examine the benefits and risks of COVID-19 vaccines.Examine the underlying causes of cardiovascular risk factors and their relationship to nutrition, including changes in the microbiome due to outcomes of COVID-19 and ethnic disparities in mortality. Evaluate various surgical methodologies for aortic arch repair, including endovascular and open options. Discuss Randomized Control Trial (RCT) outcomes related to the management of Aortic Stenosis including durability rates and those not treated in the trials.Discuss approaches to diagnosis and therapeutic strategies of gender differences in ischemic heart disease.Schedule 0700 Registration | Breakfast | Exhibitor Fair 0730 Welcome, General Overview Michael Shenoda, MD, FACC, FSCAI 0735 Opening Remarks Ron Werft, President and CEO, Cottage Health 0745 Interventional Cardiology Update Joseph Aragon, MD, FACC, FSCAI 0800 Contemporary Approach to Diagnosis and Management of HCM Martin Maron, MD, Director, Hypertrophic Cardiomyopathy Center, Lahey Clinic, Tufts University 0845 Complex Thoracic Aortic Arch Repair- Endovascular and Open Options William Brinkman, MD, Medical Director of Aortic Thoracic Surgery, Baylor Scott & White Health 0930 Break and Exhibitor Fair 0945 Keynote Presentation The Lifetime Management of Aortic Stenosis Michael J Reardon, MD, Professor of Cardiothoracic Surgery, Houston Methodist Debakey Heart and Vascular Center 1035 Panel Discussion 1100 Nutrition, the Microbiome and Cardiovascular Mortality Kim Allan Williams, Sr., M.D., MACC, FAHA, MASNC, FESC, Chair, Department of Internal Medicine, University of Louisville School of Medicine 1155 Lunch and Exhibitor Fair 1305 Direct and Indirect Effects of COVID-19 on Cardiovascular Disease Timothy D. Henry, MD, FACC, MSCAI Medical Director, The Carl and Edyth Lindner Center for Research and Education, The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, Director of Programmatic and Network Development, The Christ Hospital Physicians-Heart & Vascular 1345 Venous Ethanol Ablation of Cardiac Arrhythmias Miguel Valderrabano, MD, PhD, Chief Director, Cardiac Electrophysiology, Houston Methodist DeBakey Cardiology Associates 1430 Women and Ischemic Heart Disease: Update 2023 C Noel Bairey Merz, MD, FACC, FAHA, FESC, Director, Barbra Streisand Women's Heart Center, Linda Joy Pollin Women's Heart Health Program, Erika J. Glazer Women's Heart Research Initiative, Preventive Cardiac Center, Professor of Medicine Smidt Heart Institute Cedars-Sinai Medical Center 1515 American College of Cardiology Announcement | Stretch and Snack Break 1530 Heart Failure Management Michelle Kittleson, MD, PhD, Cedars-Sinai California Heart Center 1615 Update on SCAD (Spontaneous Coronary Artery Dissection) Jacqueline Saw, MD, Interventional Cardiologist, Clinical Professor, University British Columbia 1700 Summary and Closing Remarks Joseph Aragon, MD, FACC, FSCAI Disclosures: Dr. Aragon is a proctor for Boston Scientific, Edwards Lifesciences, Medtronic and WL Gore. He is a speaker for Shockwave Medical and Astra Zeneca. Dr. Brickman is a consultant for Medtronic, Terumo Aortic, and WL Gore. Dr. Maron is on the steering committee for Cytokinetics and a Consultant for Imbira and EdgeWise. Dr. Merz is the Board Director and is a stockholder for iRyhythm. He is receiving a research grant from Phillips. Dr. Orias is stockholder in the following companies: Pfizer, Eli Lilly, Amgen, John & Johnson, Merck, Abbott Lab, Stryker, Astra Zeneca, Glaxo Smith Klein, Edwards Lifesciences, Intuitive Surgical, and Medtronic. Dr. Reardon is a consultant for Medtronic, Boston Scientific, Abbott and Gore. Dr. Saw receives research funding from CIHR, HSFC, MSFHR and NIH. She is a consultant and Proctor for Boston Scientific and Abbott. She receives honoraria from Boston Scientific, Abbott, Astra Zeneca and Bayer. She is on the Speaker’s Bureau for Boston Scientific and Abbott. Dr. Shafer is a stockholder with Edwards Lifesciences and Medtronic. He is a consultant and speaker for Boston Scientific. Dr. Shenoda is a consultant for Edwards Lifesciences. Dr. Valderrabano is a consultant for Baylis Medical and a speaker for Boston Scientific. He receives research support and is a consultant for Circa Scientific and Biosense – Webster. All of the relevant financial relationships listed have been mitigated. All other members of the planning committee and speakers for this educational event have indicated that they have no relevant financial relationships with ineligible companies. This CME event did not receive commercial support. Credit Information The Santa Barbara County Consortium for Continuing Medical Education is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Santa Barbara County Consortium for Continuing Medical Education designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Provider approved by the California Board of Registered Nursing provider #00252 for 7 contact hours. COVID-19 safety precautions will be communicated closer to the event.

By:  view source

Discussion

By posting you agree to the Terms and Privacy Policy.

/
Search this area